Literature DB >> 8789919

A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.

D Addington1, J Addington, M Atkinson.   

Abstract

This study compared two measures of depression in a population with schizophrenia. Inpatients (n = 112) with schizophrenia, were assessed on the Hamilton (HDRS), and Calgary (CDSS) depression scales and the Positive and Negative Syndrome Scale (PANSS). Eighty-nine were reassessed 3 months later. A principal components factor analysis was applied to each depression scale. The relationship between measures of depression and positive and negative symptoms was explored using correlation, factor and regression analyses. There were no significant correlations between the total CDSS and positive or negative symptoms at either time. In contrast, the HDRS total score was correlated with both positive and negative syndromes at time 2. Moreover, a number of HDRS factors correlated significantly with the PANSS positive scale at both times and with the negative subscale score at time 2. Multiple regression analysis showed that the HDRS accounted for more of the variance in positive and negative symptoms scores than did the CDSS. The CDSS has fewer factors and less overlap with positive and negative symptoms than the HDRS. This suggests that it is a more specific measure of level of depression than the HDRS for individuals with schizophrenia.

Entities:  

Mesh:

Year:  1996        PMID: 8789919     DOI: 10.1016/0920-9964(95)00070-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  43 in total

1.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

2.  Factors associated with occupational and academic status in patients with first-episode psychosis with a particular focus on neurocognition.

Authors:  Marte Tandberg; Torill Ueland; Ole A Andreassen; Kjetil Sundet; Ingrid Melle
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-02-07       Impact factor: 4.328

3.  Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment.

Authors:  Stefan Klingberg; Andreas Wittorf; Jutta Herrlich; Georg Wiedemann; Christoph Meisner; Gerhard Buchkremer; Nicole Frommann; Wolfgang Wölwer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

4.  Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.

Authors:  Stephanie G Park; Katiah Llerena; Julie M McCarthy; Shannon M Couture; Melanie E Bennett; Jack J Blanchard
Journal:  Schizophr Res       Date:  2012-01-21       Impact factor: 4.939

5.  Evaluation of different approaches for confounding in nonrandomised observational data: a case-study of antipsychotics treatment.

Authors:  E Sarlon; A Millier; S Aballéa; M Toumi
Journal:  Community Ment Health J       Date:  2014-04-03

6.  The cognitive, affective motivational and clinical longitudinal determinants of apathy in schizophrenia.

Authors:  Stéphane Raffard; Catherine Bortolon; Hanan Yazbek; Christophe Lançon; Michel Benoit; Joanna Norton; Delphine Capdevielle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-08       Impact factor: 5.270

7.  The Role of Insight in Moderating the Association Between Depressive Symptoms in People With Schizophrenia and Stigma Among Their Nearest Relatives: A Pilot Study.

Authors:  Dzmitry Krupchanka; Mikhail Katliar
Journal:  Schizophr Bull       Date:  2016-03-12       Impact factor: 9.306

8.  Predictors of current functioning and functional decline in schizophrenia.

Authors:  Jamie Joseph; William S Kremen; Carol E Franz; Stephen J Glatt; Joyce van de Leemput; Sharon D Chandler; Ming T Tsuang; Elizabeth W Twamley
Journal:  Schizophr Res       Date:  2017-01-28       Impact factor: 4.939

9.  Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.

Authors:  Jean Addington; Hely Shah; Lu Liu; Donald Addington
Journal:  Schizophr Res       Date:  2014-01-16       Impact factor: 4.939

10.  The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.

Authors:  Katiah Llerena; Stephanie G Park; Julie M McCarthy; Shannon M Couture; Melanie E Bennett; Jack J Blanchard
Journal:  Compr Psychiatry       Date:  2013-01-22       Impact factor: 3.735

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.